1. Home
  2. INDP vs ZEO Comparison

INDP vs ZEO Comparison

Compare INDP & ZEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INDP
  • ZEO
  • Stock Information
  • Founded
  • INDP 2000
  • ZEO 2005
  • Country
  • INDP United States
  • ZEO United States
  • Employees
  • INDP N/A
  • ZEO N/A
  • Industry
  • INDP Biotechnology: Pharmaceutical Preparations
  • ZEO
  • Sector
  • INDP Health Care
  • ZEO
  • Exchange
  • INDP Nasdaq
  • ZEO NYSE
  • Market Cap
  • INDP 10.2M
  • ZEO 25.7M
  • IPO Year
  • INDP N/A
  • ZEO N/A
  • Fundamental
  • Price
  • INDP $0.94
  • ZEO $2.04
  • Analyst Decision
  • INDP Strong Buy
  • ZEO
  • Analyst Count
  • INDP 2
  • ZEO 0
  • Target Price
  • INDP $8.50
  • ZEO N/A
  • AVG Volume (30 Days)
  • INDP 25.7K
  • ZEO 2.7M
  • Earning Date
  • INDP 11-12-2024
  • ZEO 12-31-2024
  • Dividend Yield
  • INDP N/A
  • ZEO N/A
  • EPS Growth
  • INDP N/A
  • ZEO N/A
  • EPS
  • INDP N/A
  • ZEO 0.67
  • Revenue
  • INDP N/A
  • ZEO $95,455,763.00
  • Revenue This Year
  • INDP N/A
  • ZEO N/A
  • Revenue Next Year
  • INDP N/A
  • ZEO N/A
  • P/E Ratio
  • INDP N/A
  • ZEO $2.28
  • Revenue Growth
  • INDP N/A
  • ZEO N/A
  • 52 Week Low
  • INDP $0.84
  • ZEO $1.05
  • 52 Week High
  • INDP $3.10
  • ZEO $11.60
  • Technical
  • Relative Strength Index (RSI)
  • INDP 40.51
  • ZEO 54.35
  • Support Level
  • INDP $0.94
  • ZEO $1.50
  • Resistance Level
  • INDP $1.01
  • ZEO $3.05
  • Average True Range (ATR)
  • INDP 0.06
  • ZEO 0.51
  • MACD
  • INDP 0.00
  • ZEO -0.03
  • Stochastic Oscillator
  • INDP 28.24
  • ZEO 43.26

About INDP Indaptus Therapeutics Inc.

Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It has developed a proprietary platform that exploits bacteria's natural ability to activate both innate and adaptive cellular immune pathways. The company's pre-clinical candidate Decoy20, has the ability to elicit single-agent activity and durable anti-tumor responses in the combination setting against colorectal, hepatocellular, pancreatic carcinoma, and non-Hodgkin's lymphoma models.

About ZEO ZEO ENERGY CORP

Zeo Energy Corp is a vertically integrated provider of residential solar energy systems, other energy efficient equipment and related services currently serving customers in Florida, Texas, Arkansas, and Missouri. Its primary business activity is selling and installing residential solar energy systems that homeowners use to supplement the amount of usable electricity required to power their homes.

Share on Social Networks: